RxDoctor Payments Data

Jeffrey Rubnitz

Pediatric Hematology-Oncology · Memphis, TNNPI 1174526750

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $2,835 of the $2,835 with a category attached, or 100.0%. Janssen Research & Development, LLC accounts for 71.4% of it on its own, with 1 other manufacturer making up the rest. 2021 is the largest year on record at $2,025, 3.8 times the $540 reported in 2019.

$2,835in general payments, 2019–2025

Across 4 payments — averaging $708.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Janssen Research & Development, LLC$2K
  • Incyte Corporation$810
$2,405,262in research payments, 2019–2025

Across 69 payments — averaging $34,859 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$1.4M
  • Seagen Inc.$955K
  • Syndax Pharmaceuticals, Inc.$83K

What the payments were for

  • Consulting fees$2,835100%

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,835 in reported general payments places this provider in the 60th percentile of 113 pediatric hematology-oncology providers in Tennessee.

See all pediatric hematology-oncology providers in Tennessee

Other pediatric hematology-oncology in Memphis

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →